Rice researchers build dye-free molecular atlas of Alzheimer’s brain in animal model

Faktatarkistettu

Rice University scientists say they have created the first complete, label-free molecular atlas of an Alzheimer’s brain in an animal model, combining hyperspectral Raman imaging with machine learning to map chemical changes that appear unevenly across brain regions and extend beyond amyloid plaques.

Scientists at Rice University report they examined brain tissue from both healthy animals and animals with Alzheimer’s disease to create a label-free molecular atlas of the brain.

To do that, the team used hyperspectral Raman imaging, a laser-based method that detects the chemical “fingerprints” of molecules. Because the approach is label-free, the tissue samples were not treated with dyes, fluorescent proteins or molecular tags, the researchers said.

“Traditional Raman spectroscopy takes one measurement of chemical information per molecular site,” said Ziyang Wang, an electrical and computer engineering doctoral student at Rice and a first author of the study. “Hyperspectral Raman imaging repeats this measurement thousands of times across an entire tissue slice to build a full map. The result is a detailed picture showing how chemical composition varies across different regions of the brain.”

The researchers said they mapped whole brains slice by slice, collecting thousands of overlapping spectra to generate high-resolution molecular maps of healthy and diseased tissue.

To analyze the large volume of imaging data, the team applied machine-learning methods, first using unsupervised approaches to identify patterns in molecular signals and then supervised models trained on known Alzheimer’s and non-Alzheimer’s samples to gauge how strongly different brain regions reflected Alzheimer’s-related chemistry.

“We found that the changes caused by Alzheimer’s disease are not spread evenly across the brain,” Wang said. “Some regions show strong chemical changes, while others are less affected. This uneven pattern helps explain why symptoms appear gradually and why treatments that focus on only one problem have had limited success.”

According to the researchers, the results suggest Alzheimer’s-related chemical changes are not confined to amyloid plaques and include broader metabolic differences. They reported that cholesterol and glycogen levels varied across regions, with the largest contrasts in memory-linked areas including the hippocampus and cortex.

“Cholesterol is important for maintaining brain cell structure, and glycogen serves as a local energy reserve,” said Shengxi Huang, an associate professor at Rice and a corresponding author of the study. “Together, these findings support the idea that Alzheimer’s involves broader disruptions in brain structure and energy balance, not only protein buildup and misfolding.”

The study was published in ACS Applied Materials and Interfaces. The research was supported by the National Science Foundation, the National Institutes of Health and the Welch Foundation, the Rice University release said.

Wang said the effort began with measurements from small areas of brain tissue and later expanded to full-brain mapping after multiple rounds of testing to integrate the measurements and analysis.

Liittyvät artikkelit

Scientific illustration showing AI tool SIGNET mapping disrupted gene networks in Alzheimer's brain neurons.
AI:n luoma kuva

AI tool maps causal gene-control networks in Alzheimer’s brain cells

Raportoinut AI AI:n luoma kuva Faktatarkistettu

Researchers at the University of California, Irvine report that a machine-learning system called SIGNET can infer cause-and-effect links between genes in human brain tissue, revealing extensive rewiring of gene regulation—especially in excitatory neurons—in Alzheimer’s disease.

Researchers at Scripps Research have developed a blood test that detects Alzheimer's disease by analyzing structural changes in blood proteins. The method identifies differences in three specific proteins, allowing accurate distinction between healthy individuals, those with mild cognitive impairment, and Alzheimer's patients. Published in Nature Aging on February 27, 2026, the findings could enable earlier diagnosis and treatment.

Raportoinut AI

New research from the University of Southern California suggests that subtle declines in brain blood flow and oxygen delivery may be early indicators of Alzheimer's disease. The study, published in Alzheimer's and Dementia, used noninvasive scans to connect vascular health with amyloid plaques and hippocampal shrinkage. These findings highlight the role of brain circulation in the disease process beyond traditional markers like amyloid and tau.

Researchers at the University of California, San Francisco, have discovered a mechanism by which exercise helps protect the brain from age-related damage associated with Alzheimer's disease. Physical activity prompts the liver to release an enzyme that repairs the blood-brain barrier, reducing inflammation and improving memory in older mice. The findings, published in the journal Cell, highlight a body-to-brain pathway that could lead to new therapies.

Raportoinut AI

Scientists have created innovative nanoparticles designed to destroy harmful proteins linked to dementia and cancer. These particles can access difficult tissues like the brain and precisely eliminate problematic proteins without broad side effects. The technology shows early promise for precision medicine.

Tämä verkkosivusto käyttää evästeitä

Käytämme evästeitä analyysiä varten parantaaksemme sivustoamme. Lue tietosuojakäytäntömme tietosuojakäytäntö lisätietoja varten.
Hylkää